Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Breast Dis. 2010 Jan 1;31(1):7–18. doi: 10.3233/BD-2009-0290

Figure 8.

Figure 8

The maximal drug effect is summarized for KPL4 xenografts when given capecitabine at increasing doses. The solid circles represent the 7—7 schedule; open circles represent control (14—7). Capecitabine at 2.5mmol/kg/day was not deliverable at the 14—7 schedule due to mortality for study mice.